Selexipag (Uptravi)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Selexipag (Uptravi), covering 2016-03-01 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension [Phase 3]